BT-B Luciferase Reporter Cell Line
BT-B Luciferase Reporter Cell Line, transformed from BT-B cells, expressing firefly luciferase for cancer signaling, drug testing, and functional assays.
本分类收录的细胞产品与配套技术资料,支持按来源、物种与规格筛选。 共 961 个产品。
BT-B Luciferase Reporter Cell Line, transformed from BT-B cells, expressing firefly luciferase for cancer signaling, drug testing, and functional assays.
Explore BT474 (NFkB) Luciferase Reporter Cell Line for oncology assays, enabling NFkB signaling analysis, breast cancer biology, and drug discovery.
BT474 (SMAD/TGFbeta) Luciferase Reporter Cell Line,BT474 luciferase reporter model for SMAD/TGFβ signaling, oncology, and targeted drug discovery research.
BT474 (STAT3) Luciferase Reporter Cell Line enables sensitive monitoring of STAT3 transcriptional activity for oncology and drug discovery assays.
BTLA PD-1 Reporter Cell Line enables immunology research by monitoring checkpoint signaling pathways for drug development and therapeutic studies.
The BTLA Reporter Cell Line allows investigation of BTLA signaling, T cell regulation, and therapeutic targeting in immuno-oncology studies.
The BV2 EGFP Reporter Cell Line is generated from BV2 Cell Line, expressing the EGFP gene. The cells constitutively express EGFP.
BV2 Luciferase Reporter Cell Line provides luminescent monitoring for microglial activity, neuroinflammation pathways, and therapeutic drug testing.
BW5147.G.1.4 (NFkB) Luciferase Reporter Cell Line is a T-cell model for NF-κB pathway analysis, tumor immunology, and drug screening research.
BW5147.G.1.4 (SMAD/TGFbeta) Luciferase Reporter Cell Line enables precise TGF-beta signaling detection through luciferase activity in immune studies.
BW5147.G.1.4 (STAT3) Luciferase Reporter Cell Line supports STAT3 pathway research, immune signaling analysis, and drug screening applications.
The BW5147.G.1.4-NFAT Luciferase Reporter Cell Line enables NFAT pathway activation studies for the immunology and T-cell signaling research.
BxPC-3 (NFkB) Luciferase Reporter Cell Line constitutively expresses firefly luciferase, enabling luminescence assays of NFkB pathway activation.
BxPC-3 (SMAD/TGFbeta) Luciferase Reporter Cell Line provides a model for studying SMAD/TGF-beta signaling in pancreatic cancer research and studies.
The BxPC-3 (STAT3) Luciferase Reporter Cell Line enables sensitive detection of the STAT3 pathway activity in pancreatic cancer drug screening.
BxPC-3 EGFP reporter cell line enables real-time pancreatic cancer cell tracking and is suitable for imaging, drug screening, and gene expression studies.
BxPC-3 Luciferase Reporter Cell Line provides a pancreatic cancer model for transcriptional activity, signaling, and anti-cancer drug discovery.
The C-33A GFP cell line is transformed from C-33A cell, expressing the GFP gene. The cell constitutively express GFP.
C-33A Luciferase Reporter Cell Line provides bioluminescent monitoring for cervical cancer biology, pathway regulation studies, and therapeutic research.
C127 Luciferase Reporter Cell Line is optimized for pathway analysis and high-throughput screening in cancer and molecular biology research.
The C1498 GFP cell line is transformed from C1498 cell, expressing the GFP gene. The cell constitutively express GFP.
C1498 Luciferase Reporter Cell Line enables leukemia pathway studies, high-throughput drug screening, and transcriptional regulation analysis.
C2C12 (NFkB) Luciferase Reporter Cell Line enables sensitive monitoring of NF-kB activation in myoblasts for inflammation and drug testing studies.
The C2C12 (SMAD/TGFbeta) Luciferase Reporter Cell Line aids in studying TGF-beta signaling pathways in the muscle differentiation and fibrosis.
共 961 个产品 | 第 7 / 41 页